Proudfoot J - Search Results

1

Spontaneous Stereoselective Oxidation of Crystalline Avermectin B_1a to Its C-8a-(S)-Hydroperoxide.

Gliński JA, Proudfoot J, Madura I, Zhang H, Gleńsk M, Day V, Dudek MK. Gliński JA, et al. Among authors: proudfoot j. J Nat Prod. 2019 Dec 27;82(12):3477-3481. doi: 10.1021/acs.jnatprod.9b00524. Epub 2019 Dec 13. J Nat Prod. 2019. PMID: 31833374

2

Tetrazole compounds: the effect of structure and pH on Caco-2 cell permeability.

Young AM, Audus KL, Proudfoot J, Yazdanian M. Young AM, et al. Among authors: proudfoot j. J Pharm Sci. 2006 Apr;95(4):717-25. doi: 10.1002/jps.20526. J Pharm Sci. 2006. PMID: 16498570

3

Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.

Liang E, Proudfoot J, Yazdanian M. Liang E, et al. Among authors: proudfoot j. Pharm Res. 2000 Oct;17(10):1168-74. doi: 10.1023/a:1026450326712. Pharm Res. 2000. PMID: 11145220

4

A structure-permeability study of small drug-like molecules.

Fichert T, Yazdanian M, Proudfoot JR. Fichert T, et al. Bioorg Med Chem Lett. 2003 Feb 24;13(4):719-22. doi: 10.1016/s0960-894x(02)01035-1. Bioorg Med Chem Lett. 2003. PMID: 12639566

5

Nonpeptidic, monocharged, cell permeable ligands for the p56lck SH2 domain.

Proudfoot JR, Betageri R, Cardozo M, Gilmore TA, Glynn S, Hickey ER, Jakes S, Kabcenell A, Kirrane TM, Tibolla AK, Lukas S, Patel UR, Sharma R, Yazdanian M, Moss N, Beaulieu PL, Cameron DR, Ferland JM, Gauthier J, Gillard J, Gorys V, Poirier M, Rancourt J, Wernic D, Llinas-Brunet M. Proudfoot JR, et al. J Med Chem. 2001 Jul 19;44(15):2421-31. doi: 10.1021/jm000446q. J Med Chem. 2001. PMID: 11448224

6

The Pistoia Alliance Controlled Substance Compliance Service Project: from start to finish.

Taylor D, Bowden SG, Knorr R, Wilson DR, Proudfoot J, Dunlop AE. Taylor D, et al. Among authors: proudfoot j. Drug Discov Today. 2015 Feb;20(2):175-80. doi: 10.1016/j.drudis.2014.09.021. Epub 2014 Oct 2. Drug Discov Today. 2015. PMID: 25281592 Free article.

7

The evolution of synthetic oral drug properties.

Proudfoot JR. Proudfoot JR. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1087-90. doi: 10.1016/j.bmcl.2004.12.024. Bioorg Med Chem Lett. 2005. PMID: 15686918

8

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs.

Proudfoot JR. Proudfoot JR. Bioorg Med Chem Lett. 2002 Jun 17;12(12):1647-50. doi: 10.1016/s0960-894x(02)00244-5. Bioorg Med Chem Lett. 2002. PMID: 12039582

9

Discovery and SAR study of novel dihydroquinoline-containing glucocorticoid receptor agonists.

Takahashi H, Bekkali Y, Capolino AJ, Gilmore T, Goldrick SE, Kaplita PV, Liu L, Nelson RM, Terenzio D, Wang J, Zuvela-Jelaska L, Proudfoot J, Nabozny G, Thomson D. Takahashi H, et al. Among authors: proudfoot j. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5091-5. doi: 10.1016/j.bmcl.2007.07.021. Epub 2007 Jul 13. Bioorg Med Chem Lett. 2007. PMID: 17681466

10

Identification of dissociated non-steroidal glucocorticoid receptor agonists.

Kuzmich D, Kirrane T, Proudfoot J, Bekkali Y, Zindell R, Beck L, Nelson R, Shih CK, Kukulka AJ, Paw Z, Reilly P, Deleon R, Cardozo M, Nabozny G, Thomson D. Kuzmich D, et al. Among authors: proudfoot j. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5025-31. doi: 10.1016/j.bmcl.2007.07.031. Epub 2007 Jul 25. Bioorg Med Chem Lett. 2007. PMID: 17692519

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

733 results

Search Page